WHO announces global resurgence of cholera cases in 2024

The agency's Eastern Mediterranean Region reported the highest number of cases, followed by the Africa Region, the Americas Region, the…

Gilead PrEP lenacapavir succeeds in phase 3 trial

The logo of the pharmaceutical company Gilead Sciences in Oceanside, California, on April 29, 2020. Mike Blake | Reuters GileadThe…